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Abstract
Background: Indonesian mistletoe grows on various trees. Mango Mistletoes (Dendrophthoe pentandra) is one type
of mistletoe that grown on mango tree (.benalu mangga in bahasa Indonesia). Our study used mistletoe as a
parasitic plant that has been used for traditional medicine. It has been known that Dendrophtoe pentandra extract
(DPE) anti-inflammatory and anticancer. Furthermore, it is necessary to follow-up study in vivo to evaluate the
response to treatment of new cancer therapeutic agents. This research aimed to determine the levels of IL-22,
myeloperoxide (MPO), proliferation and wild-type p53 expression after the administration of DPE to murine models
of CAC.
Methods: Mouse colitis associated colon cancer (CAC) was induced firstly by azoxymethane (AOM) and followed
by administration of drinking water containing 5 % dextran sodium sulfate (DSS) in a cycle protocol, each cycle
consisted of seven days of 5 % DSS in the drinking water and followed by seven days of regular water. This study
consists of five treatment groups: I was treated water only (control), II was administrated by (DSS only, without DPE),
(III-V) were administrated by DPE (125 mg/kg BW, 250 mg/kg BW and 500 mg/kg BW) respectively. The administrated
of DPE were started from the 8th weeks, were continued until 21 weeks. At the end of 21 weeks of the experiment,
mice were sacrificed, colon tissue was removed, and then subjected to ELISA, flow cytometry, real-time PCR and
histology examination.
Results: Administration of DPE 250 mg/kgBW significantly reduce the levels of IL-22 and MPO compared with DSS
only group (p < 0.001; p < 0.001). Colonic epithelial cells proliferation of group IV (DPE 250 mg/kgBW) were significantly
lower than III and V groups. There was no significant change in the S phase in mice were treated DPE 125 mg/kg BW
and 500 mg/kg BW, while administration of DPE 250 mg/kg BW was able to increase the percentage of cells in S
phase. The expression of mRNA p53 was up regulated in mice received DPE 125 mg/kg BW.
Conclusion: These findings indicate that the DPE could inhibit colonic epithelial cells proliferation through p53
pathway independently. This study also showed that DPE could be potential sources of new therapy.
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Background
Since mistletoe is a semi-parasitic plant, it is suggests
that their bioactivities could also depend on their host
plant [1]. However people in Indonesia usually called the
mistletoe depend on the host plant where it grew, such
as benalu mangga (mistletoe which used mango as host).
Mistletoe is considers as an unwanted plant to eco-
nomically important horticultural plant, however in the
other side, mistletoe is known as one of medicinal plant
used in traditional/alternative medicine in Indonesia and
other countries such as in treatment for cough, diabetes,
hypertension, cancer, diuretic.
DPE contains quercetin-3-rhamnose [2]. Quercetin
has anti-oxidant, anti-inflammatory, anti-cancer, and im-
mune modulator effect [3–5]. Quercetin also improve
the action of the drug 5-Fluorouracil (5-FU) promoting
increased expression of p53 and apoptosis in breast
cancer T47D cells [6, 7].
Colon cancer is caused by many factors that affect
multiple etiological pathways. Important risk factors in-
clude chronic inflammation, environmental effects and
unhealthy lifestyle. All these risk factors are linked to
cancer through inflammation [8].
CAC is modeled in mice by administering AOM and
DSS. The combined administration of AOM and DSS
accelerates tumor growth [9]. The induction AOM and
DSS in Balb/C mice lead to 100 % development of
adenocarcinoma of the colon It also mimics inflammatory
reactions seen in patients with ulceratif colitis (UC) [10].
Chronic inflammation in mice model that are initiated by
the DSS causes colitis, deoxyribonucleic acid (DNA) dam-
age and encourages the emergence of adenoma [11, 12].
In CAC, intestinal inflammation play critical role that
induce DNA damage and cellular proliferation path-
way. That will lead CAC by increasing of cell signals,
cell proliferation and suppressing of tumor suppressor
and apoptosis [13, 14]. This CAC is associated with
the cell cycle and its regulation is affected by the
tumor suppressor proteins.
One of the tumor suppressor proteins such as p53 play
an important role in the cell cycle and apoptosis. The
function of p53 instead a transcription factor, targeting
several genes that play a role in the cell cycle checkpoint
and induction of apoptosis [15, 16].
Chronic inflammation causes the migration of inflam-
matory cells such as neutrophils. If the production of
neutrophils is excessive, it will cause damage to tissue
[17]. Interleukin 22 is a cytokine that is induced by cyto-
kines IL-6, IL-23, IL-1β and TNF-α under conditions of
inflammation in response to tissue damage. Interleukin-
22 binds IL-22R1 receptor complex, activates STAT3
[18] and encourage tissue repair to improve colonic
epithelial cell proliferation in acute inflammatory conditions
[19]. Interleukin-22 is deregulated in cancer conditions,
tissue regeneration regulation function is transformed into
the driving cancer development [20].
There is no information regarding the influence of
DPE treatment on CAC model. The mechanism of DPE
as anti inflammation and proliferation still unknown.
Hence we investigate the effect of DPE on the levels of
IL-22, myeloperoxide (MPO), proliferation, and expres-
sion of wild-type p53 following DPE administration to
murine models of CAC.
Methods
Plant material and extraction
Mango Mistletoes Dendrophthoe pentandra leaves were
collected from Probolinggo, East-Jawa, Indonesia. The
plant was identified and authenticated by biologists in
Department of Biology, University of Brawijaya (speci-
men No.0170/Taxonomy Identification/03/2015). The
leaves were dried for five days at room temperature and
then powdered. Leaves were macerated with 80 % etha-
nol for 72 h and then filtered. The filtrated was evapo-
rated under reduced pressure to obtain of solid form of
the extract. The quercetin content from DPE extraction
was 0.57 μg/g dry weight that quantified by thin layer
chromatography (TLC).
Mice
Female Balb/c mice, aged 8–10 weeks, weight between
20–25 g were maintained in a relative humidity of
50–55 % and a preset light–dark cycle (12:12 h) con-
dition. The mice were given normal drinking water
ad libitum during the experimental periods. Mice
have been fed with standard pellet and water ad libi-
tum. Mice were housed under specific pathogen-free
conditions and followed the institutional guidelines
concerning the care and handling animal according to
Guiding Principles for the Care and Use of Animals
for Scientific Purposes in the Institutional Animal
Care and Use Committee (IACUC). The animal studies
were performed by current regulations and ethical ap-
proval of The Ethical Committee Brawijaya University,
Malang, Indonesia (No.405-KEP-UB).
AOM and DSS-induced colon cancer model
Mice were given a single i.p. injection of 10 mg/kg azox-
ymethane (AOM; (Sigma-Aldrich, USA, Cat A5486) or
vehicle (PBS) on experimental day 1. At one week post
injection, colitis was induced by providing drinking
water containing 5 % DSS (ICN Biomedical Inc, CA,
USA) for a week. DSS was administered in a cycle proto-
col, each cycle consisting of 7 days of 5 % DSS and
followed by one week of regular water. Colon cancer
was induced by cyclical DSS treatment, which consisted
of 1 week of 5 % DSS followed by 7 days of untreated
water (Fig. 1). The oral administration of DPE starting at
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8 weeks was continued until 21 weeks [21]. Mice were
randomly divided into five groups (Fig. 1). Control group
received water (vehicle). Group ll was given 5 % DSS
only. Group (lll-V) were received DPE at 125, 250 or
500 mg/kg body weight, respectively. The dose of DPE
125 mg/kg-500 mg/kg were used previously [21]. Colon
tissue was removed and cleaned, then subjected to ELISA,
flowcytometry, qPCR and immunohistochemistry.
Colon organ culture and IL-22 level assay
Colon was washed in ice-cold PBS supplemented with
penicillin (100 μg/ml) and streptomycin (100 mg/ml).
Then, the colons were cut into small pieces and placed
into 24-well plates contain 500 ml RPMI 1640 (Sigma-
Aldrich) supplemented with 10 % FBS, 100 μg/ml
penicillin and 100 μg/ml streptomycin, and incubated
for 24 h at 37 °C, 5 % CO2. IL-22 level in the superna-
tants were determined by ELISA kit (Biolegend, USA,
Cat. 436307).
Myeloperoxidase (MPO) activity
The activity of the enzyme myeloperoxidase (MPO) was
used to assess further infiltration of neutrophils. Briefly,
the colonic protein were extracted by lysing cells in
1 mM phenylmethylsulfonyl fluoride (PMSF), 10nM
Tris, 200 mM NaCl, 3 mM EDTA, 10 % glycerol
(pH 7,4). The extracted protein was measured for MPO
levels using a mouse MPO ELISA kit according to
the manufacturer’s instructions (Elabscience Cat.
No:E- El - M2632).
Immunohistochemistry for cell proliferation
The cell proliferation patterns in the colon tissue were
assessed by using BrdU immunohistochemistry. We used
4 μm thick paraffin-embedded sections from the colons
of the mice in all groups then visualized by BrdU incorp-
oration. Briefly, paraffin-embedded colon tissue sections
were deparaffinized and hydrated. Tris–HCl buffer
(0.05 μM pH 7.6) was used to prepare solutions to rinse
slides among the various steps. Incubations were per-
formed in a humidified chamber. The sections were
treated for 40 min at room temperature with 2 % bovine
serum albumin and incubated overnight at 4 °C with
primary antibodies mouse monoclonal anti- 5-bromo-2-
deoxyuridine (BrdU) antibody (Biolegend, Cat. No:
339801) dilution of 1:200 for 1 h at room temperature.
The tissue sections were sequentially incubated with bio-
tinylated goat anti-mouse IgG (no. B0529; Sigma) and
Avidin-conjugated horseradish peroxidase (Avidin Per-
oxidase Staining Kit, Sigma) at dilution of 1:200 and
1:30, respectively. Staining was developed with diamino-
benzidine (DAB; Sigma) substrate and sections were
counterstained with hematoxylin. Sections were evalu-
ated using light microscopy and examined in a blind
fashion by two individuals separately.
Isolation and culture of mouse colon epithelial cells
The culture medium used was RPMI 1640 (Gibco) sup-
plemented with 10 % Fetal Bovine Serum (FBS), 20 mM
Hepes, 4 mM glutamine, U/ml 100 penicillin, U/ml 100
streptomycin (Sigma). Briefly, colon tissues were cut off
into 1 mm pieces. This tissue fragments were incubated
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Fig. 1 The experiment design of mice was induced Colitis Associated Colon Cancer (CAC) and DPE administration. Mouse was induced firstly by
azoxymethane (AOM) and followed by administration of drinking water containing 5 % dextran sodium sulfate (DSS) in a cycle protocol for 7 days at
weeks (1, 3, 5, 7, 9, 11, 13, 15, 17, 19 and 21) and followed by seven days of regular water at weeks (2, 4, 6, 8, 10, 12, 14, 16, 18 and 20). For the experiment,
mice were divided into 5 groups; I received water (control); II was given DSS only; III-V groups were treated DPE (125 mg/kg BW, 250 mg/kg BW and
500 mg/kg BW), respectively. The administrated of DPE were started from the 8th weeks until 21th weeks. At the end of 21 weeks, mice in all groups
were sacrificed ○ = PBS, ● = AO, ↓= DSS, ▲ = water (H2O), ↕ = DPE
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in HBSS (Sigma) at 37 °C under shaking for 30 min in
the presence of 200 U/ml type I collagenase (Sigma) and
100 U/ml hyaluronidase (Sigma), 2 mM EDTA and
25 mM Tris (Sigma). The tissue fragments were re-
suspended and incubated. The incubation procedure was
repeated for two times. The supernatant containing
colon epithelial cells were carrefully removed and centri-
fuged at 1200 rpm for 5 min at 4 °C. The supernatant
containing the purified epithelial cells were collected by
centrifugation at 1200 rpm at 4 °C then separated by
Percoll (Sigma) density gradient.
Cell cycle assay of epithelial cells
The cell cycle progression was assessed with BrdU
followed by labeling with FITC conjugated anti-BrdU
antibody and Propidium Iodide staining. Briefly, the epi-
thelial cells were seeded in 24 well tissue culture plates
(1×106 cells per well). Then cells were allowed to settle
for 24 h, and maintained at 37 °C in 5 % CO2 and 95 %
humidity, and then the medium was replaced with 1 ml
of medium containing 5 μmol BrdU. After incubation,
epithelial cells were washed with phosphate buffered sa-
line (PBS), harvested by 0.25 % trypsin, and fixed in ice-
cold 70 % ethanol for 40 min. The cells were centrifuged
and re-suspended nuclei in 1 ml 2 M HCl for 30 min at
37 °C. The epithelial cells were incubated in 2 ml 0.1 M
sodium tetraborate (pH = 8.5) for 10 min at room
temperature. Then, cells were permeabilized by 0.1 %
Tween-20-1 % BSA in PBS for 5 min at room
temperature, followed by staining with mouse anti BrdU
(Biolegend, Cat. No:339801) in PBS and the nuclear
DNA was stained with 20 μg/ml propidium iodide (PI,
Sigma) at room temperature for 30 min. Finally, the epi-
thelial cells were analyzed by using a BD FACS Calibur
flow cytometer (Becton Dickinson, San Jose, CA, USA).
RNA isolation and relative quantification by real time PCR
The level of p53 mRNA in the colon tissue was deter-
mined by real time PCR. Total RNA was extracted by
using Tri Reagent according to the manufacturer’s in-
structions (MP Bio). according to the manufacturer’s
protocol. The yield and purity of RNA was quantified by
nano spectrophotometry at 260 and 280 nm. Total RNA
(1 μg/ml) were reverse transcribed to to cDNA by using
First Strand cDNA Synthesis (Gbioscience Cat. 786–
814) according to the manufacturers. A real time assay
was performed according to Light Cycler-Fast Start
DNA MasterPLUS SYBR Green I (Roche Applied Science
Light Cycler® Diagnostic, USA) Primer sequences were:
p53 Forward 5′CCG ACC TAT CCT TAC CAT CATC
3′, Reverse 5′TTC TTC TGT ACG GCG GTC TTC TC
3′. β-actin Forward 5′TGG AAT CCT GTG GCA TCC
ATG AAA C 3′, Reverse 5′TAA AAC GCA GCT CAG
TAA CAG TCC G 3′.
The amplification program consisted of the following
steps: pre-incubation at 95 °C was 10 min, followed by
40 cycles of denaturation was 95 °C was 10 s, annealing
was 50 °C for 20 s and extension was 25 s. Each gene ex-
pression was normalized with β-actin mRNA content
[22]. The relative induction of mRNA expression com-
parative Ct was calculated using ΔΔCt was calculated
using following formula: (Ct target - Ct β-actin) treat-
ment - (Ct target - Ct β-actin) non treatment.
Statistical analysis
The data were reported as mean ± standard deviation.
The statistical significance was evaluated by using 1-way
ANOVA (p < 0.05), followed by Post Hoc Tukey test.
Results
Dextran sulfate sodium induced colitis associated cancer
(CAC)
Based on previous studies, DSS was used in combination
with AOM, received a chemical carcinogen which in-
duces colorectal cancer in mice. After receiving 3 cycles
of DSS administration, mice received various doses
group lll (doses (125 mg/kg), group lV (250 mg/kg) and
group V (500 mg/kg). At the end of 21 weeks, mice in
group ll (DSS only or DPE (−) had diarrhea and occult
blood in feces. Blood in the feces was detected using an
occult blood detection kit (Hemoccult). Body growth
rate was slightly lower in the mice that received DSS
administration only (Fig. 1).
DPE decreased the level of IL-22 in the colon of CAC
models
AOM and DSS administration increase IL-22 levels in
supernatant colon culture significantly (p = 0.000). The
administration of DPE at all doses in group lll (doses
(125 mg/kg), p = 0.000; group lV (250 mg /kg), p = 0.000,
group V (500 mg/kg) p = 0.010) decreased the levels of
IL-22 significantly compared with DPE (−) group (Fig. 2).
The greatest decrease was a dose of DPE (250 mg/kg).
DPE decreased level of MPO
The MPO level in DSS only group was higher signifi-
cantly when compared with DPE treatment group (p =
0.02). The DSS only group showed extensive ulceration,
with severe inflammatory cell infiltration. Administra-
tion of DPE caused significantly decrease MPO levels in
DSS group compared to DPE ll and lll group (p = 0.01;
p = 0.02) whereas treatment with DPE l group (125 mg
/kg) did not affect DSS-treated mice (Fig. 3).
DPE suppresses colonic epithelial cells proliferation
This study, epithelial cells proliferation was observed by
using anti-BrdU staining performed by Immunohisto-
chemistry. The microscopic appearance of colonic
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epithelial cells of CAC mice model showed undergo pro-
liferation in DSS only group. Colonic epithelial cells pro-
liferation was significantly higher in DSS-induced CAC
models than DPE treatment groups (p = 0.02) (Fig. 4).
Administration of DPE could decreased proliferation of
epithelial cells. In this study, DPE suppressed carsino-
genesis by reducing the proliferation of epithelial cells.
DPE inhibits S phase of the cell cycle
We examined whether colonic epithelial cells were rest-
ing or proliferating state. DNA synthesis was measured
in colonic epithelial cells followed. The percentage of
BrdU-labeled S-phase cells were determined by observ-
ing labeled cells undergoing of the S-phase of the cell
cycle. Our data demonstrated that colonic epithelial cells
in CAC models without DPE treatment were predomin-
antly in S phase (45 %), in G0/G1 phase (28 %), and in
G2/M (26 %). Induction of DPE treatment change the
percentage of cells in S phase through not in a dose
dependent manner. DPE of 125 mg/kg BW (S phase =
36 %), 250 mg/kg BW (S phase = 17 %) and 500 mg/kg
BW (S phase = 30 %) (Fig. 5).
DPE up regulated p53 wild-type gene expression in the
colon of CAC models
The AOM and DSS administration to Balb/C mice de-
creased the expression of p53 (p = 0.029). The expression
of p53 at DSS only group decreased 49 % when com-
pared with mice were received DPE of 125 mg/kg BW
group. The expression of p53 responded to administra-
tion of DPE in a manner inversely doses dependent. The
dose of DPE 125 mg group slightly increased p53 ex-
pression when it was compared with a DSS only group
(p = 0.06). The difference was not statistically significant
between DPE I 125 mg/kg, DPE II DPE 250 mg/kg and
III DPE 500 mg/kg groups. Although there were slightly
increased p53 expression in DPE I 125 mg/kg treatment
group, the colons from CAC mice (Fig. 6).
Discussions
In this study, we demonstrated the effect of DPE on the
levels of IL-22, MPO, proliferation and wild type p53 ex-
pression in CAC mouse models. Further we analyzed
the levels of IL-22 in the DSS only group were signifi-
cantly higher than DPE treated groups (I and II group,
(p < 0.001; p < 0.001). We have shown that administra-
tion of DPE to CAC models could decrease IL-22 and
proliferation levels. DPE given to murine CAC models
would be expected to decrease COX-2 and proinflam-
matory cytokine, which are indicators of IL-22 produc-
tion [23]. Thus, in our study, DPE administration led to
a significant reduction of proliferation, which was ac-
companied by decreased IL-22, so that it would be cap-
able of suppressing the progression of CAC. This result
is consistent with the report that D. pentandra extract
that contain quercetin could inhibit the proliferation of
a wide range of cancers such as prostate, cervical, lung,
breast, and colon [24, 25].
In our study also demonstrated in DPE treated group
was reduced the MPO levels. The results of the current
study indicated that the ability of mice to develop CAC
was inhibited by the administration of the DPE treat-
ment. Mice were administered DPE 250 mg/kg and
500 mg/kg exhibited significantly lower MPO levels
compared with untreated DPE group (p = 0.01; p = 0.00).
This finding suggests that DPE treated mice were
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Fig. 2 DPE decreased IL-22 levels in CAC murine models. IL-22 levels
were measured from supernatants of colon organ culture by enzyme
linked immunosorbent assay. Each group consisted of at least four
mice. Results shown are mean + SD, with n = 4 replicates in each
group. Results are mean ± SD. *, p < 0.05. **, p < 0.001
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Fig. 3 DPE decreased MPO levels in CAC murine models. The activity of
the enzyme myeloperoxidase (MPO) was used to evaluate infiltration of
neutrophils. MPO levels were measured from lysed colon cells. Each
group consisted of at least four mice. Results shown are mean + SD,
with n= 4 replicates in each group. Results are mean ± SD. *, p< 0.05.
**, p< 0.001
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protected from inflammation. Neutrophils would amplify
inflammation by secreting enzyme myeloperoxidase
(MPO) to release the inflammatory mediators. It has been
known that DPE contains quercetin, a compound that has
function as inflammation inhibitor [20] by blocking phos-
phorylation inhibitors Kappa B (IKB) [3, 4, 26].
Our results show that DPE treatment causes G1 arrest
of cell cycle. This study demonstrated that DPE treat-
ment induce cell cycle inhibition in S phases. Here we
show that DPE treatment impedes S-phase. This led to
an examination of the molecular mechanisms of cell
cycle regulation by DPE. A prominent cell cycle arrest at
S phase was noted upon treatment with quercetin [27].
Besides, an reduce of cells in S phase was observed in
DPE administration. This suggests that quercetin might
restrain DNA synthesis. A similar G1/S phase arrest has
been observed previously as well [28, 29]. Our results
indicate that DPE induced p53-mediated inhibition of S
phase in cell cycle.
The tumor suppressor protein (p53) plays a central
role in cancer prevention and therapy. The regulation of
p53 occurs in cell cycle in a variety of cells [30, 31]. In
addition, DPE has up-regulated p53 function and pro-
gression at the S cell cycle phase. DPE might increase
p53 expression at 125 mg/kg, indicating that DPE was
able to prevented excessive cell inflammation. DPE
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Fig. 4 Colonic proliferation cells from the colon CAC mice models. The cell proliferation patterns in the colon tissue were assessed by using BrdU
immunohistochemistry. Epithelial proliferation enhanced in colon of CAC mice model. Colon tissues were treated with anti BrDu antibody counterstained
with hematoxylin and visualized under the light microscope. Cell proliferation identified by BrdU immunohistochemical staining of paraffin section. Brown-
color nucleus indicates BrdU-positive cells. (A) Control group received water, (B) Group was administrated DSS 5 % only, (C), (D) and (E)
mice were administrated DPE orally 125, 250 and 500 mg/kg, respectively. Red arrow: the BrdU positive cell. All images were magnified at 400x and
representative four independent experiments with consistent results. (F). Number of BrdU positive cells. Results shown are mean + SD, with n = 4
replicates in each group. Results are mean ± SD. *, p < 0.05. **, p < 0.001
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promoted DNA synthesis as indicated by the lack presen-
tation of S phase, and they were functionally able to sup-
press the development of proliferation. Meanwhile, DPE
in high doses may cause increased risk of toxicity. In our
study DPE was administered daily for 14 weeks. This find-
ing suggested that the accumulation of toxic substances
could effects of p53 expression. The tumor suppressor
p53 as a major regulator of cell cycle progression in re-
sponse to arrest of DNA synthesis [31–34]. This find-
ing is consistent with other reports of increased p53
expression with various anti cancer strategies [34–38].
Conclusion
In conclusion, DPE can induce cytotoxicity through
multiple routes of action. Our results show that DPE
could prevent proliferation by inhibition of S phase
through induce p53 expression. Therefore, our results
suggest that DPE is a promising candidate in cancer
therapeutics.
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